Gastrointestinal symptoms in morbid obesity

Mustafa Huseini, G Craig Wood, Jamie Seiler, George Argyropoulos, Brian A Irving, Glenn S Gerhard, Peter Benotti, Christopher Still, David D K Rolston, Mustafa Huseini, G Craig Wood, Jamie Seiler, George Argyropoulos, Brian A Irving, Glenn S Gerhard, Peter Benotti, Christopher Still, David D K Rolston

Abstract

Background: Several reports have shown an increased prevalence of gastrointestinal (GI) symptoms in obese subjects in community-based studies. To better understand the role of the GI tract in obesity, and because there are limited clinic-based studies, we documented the prevalence of upper and lower GI symptoms in morbidly obese individuals in a clinic setting.

Objective: The aim of our study was to compare the prevalence of GI symptoms in morbidly obese individuals in a weight management clinic with non-obese individuals with similar comorbidities as morbidly obese individuals in an Internal Medicine clinic.

Methods: Class II and III obese patients BMI >35 kg/m(2) (N = 114) and 182 non-obese patients (BMI <25 kg/m(2)) completed the GI symptoms survey between August 2011 and April 2012 were included in this study. The survey included 24 items pertaining to upper and lower GI symptoms. The participants rated the frequency of symptoms as absent (never, rarely) or present (occasionally, frequently). The symptoms were clustered into five categories: oral symptoms, dysphagia, gastroesophageal reflux, abdominal pain, and bowel habits. Responses to each symptom cluster were compared between obese group and normal weight groups using logistic regression.

Results: Of the 24 items, 18 had a higher frequency in the obese group (p < 0.005 for each). After adjusting for age and gender, the obese patients were more likely to have upper GI symptoms: any oral symptom (OR = 2.3, p = 0.0013), dysphagia (OR 2.9, p = 0.0006), and any gastroesophageal reflux (OR 3.8, p < 0.0001). Similarly, the obese patients were more likely to have lower GI symptoms: any abdominal pain (OR = 1.7, p = 0.042) and altered bowel habits (OR = 2.8, p < 0.0001).

Conclusion: These observations suggest a statistically significant increase in frequency of both upper and lower GI symptoms in morbidly obese patients when compared to non-obese subjects.

Keywords: body mass index; clinic-based studies; gastrointestinal; obesity; symptoms.

Figures

Figure 1
Figure 1
Percent of normal weight (N = 182) and class II and III obese (N = 114) patients with occasional/frequent symptoms in each symptom group.

References

    1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2014) 384(9945):766–81.10.1016/S0140-6736(14)60460-8
    1. Olshansky SJ, Passaro DJ, Hershow RC, Layden J, Carnes BA, Brody J, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med (2005) 352(11):1138–45.10.1056/NEJMsr043743
    1. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics. NCHS Obesity Data; Available from:
    1. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) (2009) 28(5):w822–31.10.1377/hlthaff.28.5.w822
    1. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA (2005) 293(15):1861–7.10.1001/jama.293.15.1861
    1. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA (2003) 289(2):187–93.10.1001/jama.289.2.187
    1. Wood GC, Chu X, Manney C, Strodel W, Petrick A, Gabrielsen J, et al. An electronic health record-enabled obesity database. BMC Med Inform Decis Mak (2012) 12:45.10.1186/1472-6947-12-45
    1. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc (1994) 69(6):539–47.10.1016/S0025-6196(12)62245-9
    1. Delgado-Aros S, Locke GR, III, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol (2004) 99(9):1801–6.10.1111/j.1572-0241.2004.30887.x
    1. Djarv T, Wikman A, Nordenstedt H, Johar A, Lagergren J, Lagergren P. Physical activity, obesity and gastroesophageal reflux disease in the general population. World J Gastroenterol (2012) 18(28):3710–4.10.3748/wjg.v18.i28.3710
    1. Dutta SK, Arora M, Kireet A, Bashandy H, Gandsas A. Upper gastrointestinal symptoms and associated disorders in morbidly obese patients: a prospective study. Dig Dis Sci (2009) 54(6):1243–6.10.1007/s10620-008-0485-6
    1. van Oijen MG, Josemanders DF, Laheij RJ, van Rossum LG, Tan AC, Jansen JB. Gastrointestinal disorders and symptoms: does body mass index matter? Neth J Med (2006) 64(2):45–9.
    1. Anand G, Katz PO. Gastroesophageal reflux disease and obesity. Gastroenterol Clin North Am (2010) 39(1):39–4610.1016/j.gtc.2009.12.002
    1. Locke GR, III, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ, III. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 106(6):642–9.10.1016/S0002-9343(99)00121-7
    1. Nocon M, Labenz J, Jaspersen D, Meyer-Sabellek W, Stolte M, Lind T, et al. Association of body mass index with heartburn, regurgitation and esophagitis: results of the progression of gastroesophageal reflux disease study. J Gastroenterol Hepatol (2007) 22(11):1728–31.10.1111/j.1440-1746.2006.04549.x
    1. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med (2005) 143(3):199–211.10.7326/0003-4819-143-3-200508020-00006
    1. Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol (2006) 101(11):2619–28.10.1111/j.1572-0241.2006.00849.x
    1. Lundell L, Ruth M, Sandberg N, Bove-Nielsen M. Does massive obesity promote abnormal gastroesophageal reflux? Dig Dis Sci (1995) 40(8):1632–5.10.1007/BF02212682
    1. O’Brien TF., Jr Lower esophageal sphincter pressure (LESP) and esophageal function in obese humans. J Clin Gastroenterol (1980) 2(2):145–810.1097/00004836-198006000-00007
    1. Wu JC, Mui LM, Cheung CM, Chan Y, Sung JJ. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology (2007) 132(3):883–9.10.1053/j.gastro.2006.12.032
    1. Sugerman HJ, DeMaria EJ, Felton WL, III, Nakatsuka M, Sismanis A. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology (1997) 49(2):507–11.10.1212/WNL.49.2.507
    1. Pandolfino JE, El-Serag HB, Zhang Q, Shah N, Ghosh SK, Kahrilas PJ. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology (2006) 130(3):639–49.10.1053/j.gastro.2005.12.016
    1. Rieder F, Cheng L, Harnett KM, Chak A, Cooper GS, Isenberg G, et al. Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities. Gastroenterology (2007) 132(1):154–65.10.1053/j.gastro.2006.10.009
    1. Kato M, Watabe K, Hamasaki T, Umeda M, Furubayashi A, Kinoshita K, et al. Association of low serum adiponectin levels with erosive esophagitis in men: an analysis of 2405 subjects undergoing physical check-ups. J Gastroenterol (2011) 46(12):1361–7.10.1007/s00535-011-0453-3
    1. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA (2003) 290(1):66–72.10.1001/jama.290.1.66
    1. Bernal-Reyes R, Monzalvo Lopez A, Bernal-Serrano M. [Prevalence of gastrointestinal symptoms in overweight and obese subjects: an epidemiologic study on a Mexican population]. Rev Gastroenterol Mex (2013) 78(1):28–34.10.1016/j.rgmx.2012.10.006
    1. Hutson WR, Wald A. Obesity and weight reduction do not influence gastric emptying and antral motility. Am J Gastroenterol (1993) 88(9):1405–9.
    1. Kim DY, Camilleri M, Murray JA, Stephens DA, Levine JA, Burton DD. Is there a role for gastric accommodation and satiety in asymptomatic obese people? Obes Res (2001) 9(11):655–61.10.1038/oby.2001.89
    1. Fysekidis M, Bouchoucha M, Bihan H, Reach G, Benamouzig R, Catheline JM. Prevalence and co-occurrence of upper and lower functional gastrointestinal symptoms in patients eligible for bariatric surgery. Obes Surg (2012) 22(3):403–10.10.1007/s11695-011-0396-z
    1. Pourhoseingholi MA, Kaboli SA, Pourhoseingholi A, Moghimi-Dehkordi B, Safaee A, Mansoori BK, et al. Obesity and functional constipation; a community-based study in Iran. J Gastrointestin Liver Dis (2009) 18(2):151–5.
    1. Eslick GD. Prevalence and epidemiology of gastrointestinal symptoms among normal weight, overweight, obese and extremely obese individuals. Gastroenterol Clin North Am (2010) 39(1):9–22.10.1016/j.gtc.2009.12.007
    1. Crowell MD, Cheskin LJ, Musial F. Prevalence of gastrointestinal symptoms in obese and normal weight binge eaters. Am J Gastroenterol (1994) 89(3):387–91.
    1. Talley NJ, Quan C, Jones MP, Horowitz M. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil (2004) 16(4):413–9.10.1111/j.1365-2982.2004.00530.x
    1. Delgado-Aros S, Camilleri M, Garcia MA, Burton D, Busciglio I. High body mass alters colonic sensory-motor function and transit in humans. Am J Physiol Gastrointest Liver Physiol (2008) 295(2):G382–8.10.1152/ajpgi.90286.2008
    1. Depoortere I. Taste receptors of the gut: emerging roles in health and disease. Gut (2014) 63(1):179–90.10.1136/gutjnl-2013-305112
    1. Troke RC, Tan TM, Bloom SR. The future role of gut hormones in the treatment of obesity. Ther Adv Chronic Dis (2014) 5(1):4–1410.1177/2040622313506730
    1. Dockray GJ. Gastrointestinal hormones and the dialogue between gut and brain. J Physiol (Lond) (2014) 592(Pt 14):2927–41.10.1113/jphysiol.2014.270850
    1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology (2006) 130(5):1480–9110.1053/j.gastro.2005.11.061
    1. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ, III. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 65(11):1456–79.10.1016/S0025-6196(12)62169-7
    1. Cobanoglu C, Moreo P, Warde B. A comparison of mail, fax and web-based survey methods. Int J Market Res (2001) 43(4):441–52.
    1. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol (1997) 50(10):1129–36.10.1016/S0895-4356(97)00126-1

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera